Pfizer (PFE) Revenue — Quarter Ended Dec 31, 2023
Revenue for the quarter increased compared to the immediately preceding quarter. However, revenue declined sharply compared to the same quarter one year earlier.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 Q4
Revenue for the quarter increased compared to the immediately preceding quarter. However, revenue declined sharply compared to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$14.6B
Revenue reported for this quarter.
Quarter-over-quarter
+8.0%
Change from the immediately preceding quarter.
Year-over-year
-42.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$59.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Apr 2, 2023 | $18.5B | -28.0% |
| Jul 2, 2023 | $13B | -53.1% |
| Oct 1, 2023 | $13.5B | -40.4% |
| Dec 31, 2023 | $14.6B | -42.0% |
Revenue performance
The reported revenue direction is upward from the prior quarter, indicating a sequential improvement. The trailing twelve-month revenue reflects the cumulative performance over the past year.
Quarterly comparison
Compared to the immediately preceding quarter, revenue rose. Compared to the same quarter one year earlier, revenue was significantly lower.
What to watch
Monitor whether the sequential revenue growth can be sustained in future quarters.